The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases

Dong, RR; Ji, JL; Liu, H; He, XX

Dong, RR (reprint author), 3333 Binsheng Rd, Hangzhou 310052, Zhejiang, Peoples R China.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019; 143 (): 20

Abstract

Approximately 30-50% of advanced human epidermal growth factor receptor 2 (HER2) positive breast cancer patients will develop brain metastases (BMs) d......

Full Text Link